HCFP/Capital Partners 18B-2 LLC 13D/13G Filings for Scopus BioPharma Inc. (SCPS)

HCFP/Capital Partners 18B-2 LLC 13D and 13G filings for Scopus BioPharma Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2021-11-26
5:00 pm
Sale		 2021-11-23 13D Scopus BioPharma Inc.
SCPS		 HCFP/Capital Partners 18B-2 LLC 237,092
1.100%		 -2,994,150decrease
(-92.66%)		 Filing
2021-08-12
07:13 am
Purchase		 2021-08-02 13D Scopus BioPharma Inc.
SCPS		 HCFP/Capital Partners 18B-2 LLC 3,231,242
15.300%		 3,231,242increase
(New Position)		 Filing